Security and asset marking monkeypox Pharmaceuticals COVID-19 Government and Military Corporate/Financial News Personal care Printing and Packaging
APDN to Report Q1 FY’23 Financial Results; Investor Conference Call/Webcast 2/9
February 2, 2023
Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results
December 14, 2022
APDN to Establish N. America’s 1st Enzymatic Large-Scale cGMP DNA Manufacturing Capacity in NY
October 24, 2022
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
September 30, 2022
APDN, Cornell University College of Veterinary Medicine Research Collaboration
September 8, 2022
Get Social